Skip to main content
OpenTrials

Clinical trial condition

Neoplasms

Explore clinical trials studying Neoplasms. Study availability and eligibility vary by location and protocol.

7,935 public trials 1,510 recruiting studies
Refine in advanced search Browse all conditions

Neoplasms trial results

Active, Not Recruiting

Efficacy of a Systematic Referral to Palliative Care of Patients Who Need for Palliative Care During an Unscheduled Visit in Comprehensive Anticancer Centers

NCT06150027

Conditions
Cancer, Disease Attributes, Emergencies, +3 more
Locations
  • Centre Léon Bérard Lyon, France
  • ICM Val d'Aurelle Montpellier, France
  • Institut Curie - Paris Paris, France
  • Institut Curie - Saint Cloud Saint-Cloud, France
View Trial Details
Active, Not Recruiting

Nous-209 Genetic Vaccine for the Treatment of Microsatellite Unstable Solid Tumors

NCT04041310

Conditions
Digestive System Diseases, Digestive System Neoplasms, Gastrointestinal Diseases, +6 more
Locations
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • City of Hope Comprehensive Cancer Center Irvine, California, United States
  • USC Norris Comprehensive Cancer Center Los Angeles, California, United States
  • USC Norris Comprehensive Cancer Center Newport Beach, California, United States
View all 46 locations
View Trial Details
Active, Not Recruiting

A Phase 1b/2 Multisite Dose-finding and Expansion Study of WTX-330 in Adult Patients With Selected Advanced or Metastatic Solid Tumors or Lymphoma

NCT06939283

Conditions
Advanced or Metastatic Solid Tumors, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
Locations
  • HonorHealth Research Institute Scottsdale, Arizona, United States
  • Emory Winship Cancer Institute Atlanta, Georgia, United States
  • Northwestern University Chicago, Illinois, United States
  • Indiana University Melvin and Bren Simon Comprehensive Cancer Center Indianapolis, Indiana, United States
View Trial Details
Active, Not Recruiting

Dose Escalation and Expansion Study of WTX-124 as Monotherapy and in Combination With Pembrolizumab (Pembro) in Patients With Selected Advanced or Metastatic Solid Tumors

NCT05479812

Conditions
Adenocarcinoma, Advanced Solid Tumor, Bronchial Neoplasms, +37 more
Locations
  • HonorHealth Scottsdale, Arizona, United States
  • Moffitt Cancer Center Tampa, Florida, United States
  • Emory Winship Cancer Institute Atlanta, Georgia, United States
  • Northwestern University Chicago, Illinois, United States
View all 14 locations
View Trial Details

Related conditions